2cureX invited to present IndiTreat® and clinical data at ESMO in June 2018
2cureX AB (“2cureX”) announce that it has been invited to present results of the IndiTreat® clinical trial at the ESMO World Congress on Gastrointestinal Cancer 2018 in Barcelona. ESMO (European Society for Medical Oncology) is Europe’s leading medical oncology organisation with more than 18.000 oncology professionals. The IndiTreat® trial is progressing according to plan with the first ten patients enrolled.The clinical trial was launched in Denmark end of October 2017 and will this year be extended to Germany (University Medical Center Hamburg-Eppendorf) and the United Kingdom (Queen